Resumen

TALAVERA, Gricelda, RODRIGUEZ, Magdalena, CASTRO, Héctor et al. Colonización intestinal por enterococo resistente a la vancomicina en pacientes  oncológicos con factores de riesgo. Pediatr. (Asunción), ago. 2011, vol.38, no.2, p.123-125. ISSN 1683-9803.

The study objectives were to determine the prevalence of intestinal colonization by vancomycin-resistant enterococci (VRE) in cancer patients with risk factors and describe their clinical and demographic characteristics. A longitudinal study conducted between December 1, 2008 and March 30, 2010, in patients aged ≤18 years. A total of 33 patients were included. VRE were isolated in 94% (31/33), of whom 39% (12/31) were age 10-14 years. 58% (18/31) were male, and 21/31 presented acute lymphoblastic leukemia (ALL). All had previously received antibiotics, 90% (28/31) vancomycin. 84% (26/31) had central venous catheters (CVC), 2/31 had surgery, and 1/31 MV. Contact precautions were implemented. In conclusion, a high rate of VRE colonization was observed. CVC and use of vancomycin were predominant. It is important to continue the established measures, monitoring, and the prudent use of vancomycin.

Palabras claves: Vancomycin-resistant enterococci; intestinal colonization; cancer patients; pediatrics.